Question 1

What is Insulin Aspart used for?

Accepted Answer

Insulin Aspart replaces or supplements natural insulin to control blood sugar in diabetes.

Question 2

Is there a generic for Insulin Aspart?

Accepted Answer

No. Insulin Aspart is brand-only with no generic equivalents currently in market.

Question 3

How much does my plan pay for Insulin Aspart?

Accepted Answer

Across 329 Part D plans, Insulin Aspart averages $8.12/unit (NADAC). Lowest available: $6.94/unit. Highest in distribution: $8.96/unit.

Question 4

Is Insulin Aspart on the FDA shortage list?

Accepted Answer

Insulin Aspart has been discontinued by its manufacturer(s).

Question 5

What drug class is Insulin Aspart in?

Accepted Answer

Insulin Aspart is in the Insulin Analog class. See related drugs in this class at /class/insulin-analog.

Question 6

What is the brand name for Insulin Aspart?

Accepted Answer

Insulin Aspart is sold under brand names: .Insulin Aspart Protamine and Insulin Aspart, Fiasp, Insulin Aspart Protamine and Insulin Aspart, NOVOLOG, NOVOLOG MIX 70/30.

Question 7

Is .Insulin Aspart Protamine and Insulin Aspart the same as Insulin Aspart?

Accepted Answer

Yes. .Insulin Aspart Protamine and Insulin Aspart is a brand name for Insulin Aspart. The generic version is identical in active ingredient, dose, and FDA-approved indications. Pricing differs substantially: generic Insulin Aspart typically prices well below brand .Insulin Aspart Protamine and Insulin Aspart.

Question 8

How much does Medicare spend on Insulin Aspart per year?

Accepted Answer

Medicare Part D spent $704.9M on Insulin Aspart in CY2024, across 3.4M prescriptions and 1.3M unique beneficiaries.

Question 9

Why is Insulin Aspart on Tier 3 across most plans?

Accepted Answer

Insulin Aspart appears on Tier 3 in 1191 plan-NDC pairs and Tier 1 in only 289. The reason is structural: PBM rebate guarantees on brand-tier placement reduce the PBM's incentive to move the molecule to a lower tier even when generic competition exists. Moving to Tier 1 is typically possible only at plan-year reset or via contract renegotiation.

Question 10

What can I switch to instead of Insulin Aspart?

Accepted Answer

Same-class alternatives include: Diluent, Insulin Aspart Injection, Insulin Aspart-Szjj. Whether substitution is clinically appropriate depends on patient indication, dose schedule, and contraindications — that is a P&T committee decision. The federal data shows cost and competition; clinical equivalence is not asserted here.

Question 11

When was Insulin Aspart first FDA approved?

Accepted Answer

Insulin Aspart received its first FDA approval on 2001-08-27.

Insulin Aspart (.Insulin Aspart Protamine and Insulin Aspart)

$704.9M in CY2024 Part D spend3.4M claims · 1.3M beneficiaries · 329 plans surveyed

Questions a plan sponsor actually asks.

Related questions.

Same class. Different math.

Sources · every number above traces back.